| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/10/2009 | US7488805 Apoptosis proteins |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488755 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488724 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488712 Histone deacetylase inhibitors and methods for producing the same |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | CA2458067C Use of flibanserin in the treatment of sexual disorders |
| 02/10/2009 | CA2451229C Indole derivatives |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2380904C Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2286671C Method and formulation for treating vascular disease |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/10/2009 | CA2208671C Substituted imides as tnf inhibitors |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/05/2009 | WO2009018505A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | WO2009017236A1 Pyridopyrimidin-4-one derivatives |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009017190A1 Fused bicyclic compound |
| 02/05/2009 | WO2009017098A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/05/2009 | WO2009016855A1 Method of preventing hair loss and method of preventing hair depigmentation |
| 02/05/2009 | WO2009016440A1 Effervescent solid pharmaceutical composition comprising dextrose and process for its preparation |
| 02/05/2009 | WO2008109120A3 P53-mediated skin pigmentation |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036549 Substance-encapsulated carbon nanohorn complex and producing method thereof |
| 02/05/2009 | US20090036546 Medicinal Oil Compositions, Preparations, and Applications Thereof |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036507 Bis (cyanophenyl) methyl-triazole for use in prevention of breast cancer |
| 02/05/2009 | US20090036502 Thiadiazole Compounds and Uses Thereof |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036417 Cochleates without metal cations as bridging agents |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036383 Compositions and methods for promoting lipid mobilization in humans |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036354 Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090035752 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 02/05/2009 | US20090035396 Novel reference plant, a method for its production, extracts obtained therefrom and their use |
| 02/05/2009 | US20090035368 Embedded micellar nanoparticles |
| 02/05/2009 | US20090035355 Confectionery products and process for obtaining them |
| 02/05/2009 | US20090035352 Drug Delivery Particle |
| 02/05/2009 | US20090035318 Method and composition for increasing the engraftment efficiency of stem cells |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035278 Reoviruses having modified sequences |
| 02/05/2009 | US20090035270 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha |
| 02/05/2009 | US20090035267 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035250 Compositions and methods for treating cavity conditions |
| 02/05/2009 | US20090035220 high throughput screening system and method |
| 02/05/2009 | US20090035216 Method for determining in vivo biopharmaceutical concentration or bioavailability |
| 02/05/2009 | DE19805822B4 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel 11-acetyl-12,13-dioxabicyclo [8.2.1] tridecenon derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/05/2009 | CA2698305A1 Effervescent solid pharmaceutical composition comprising dextrose and process for its preparation |
| 02/05/2009 | CA2694700A1 Compositions and methods for soft tissue augmentation |
| 02/05/2009 | CA2694567A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/05/2009 | CA2694510A1 Treatment with .alpha.7-selective ligands |
| 02/05/2009 | CA2694504A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020411A1 Spiro tetracyclic compound |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2020232A1 N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/04/2009 | EP2020229A1 Multiparticulate modified release composition |
| 02/04/2009 | EP2019690A2 Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu's reaction |
| 02/04/2009 | EP2019590A1 Methods for treating diseases involving stress-related diseases and conditions |
| 02/04/2009 | EP1299529B1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/2009 | CN101360507A Method of using guava extract and composition including guava extract |
| 02/04/2009 | CN101360500A Use of morpholino compounds for the treatment of halitosis |
| 02/04/2009 | CN101357946A Cholesterol metabolic regulation protein and use thereof |
| 02/04/2009 | CN101357893A Ethylene diamine metalloid protease inhibitor and use thereof |
| 02/04/2009 | CN101357223A Preparation method of anti-stress agent for fishing |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 02/04/2009 | CN100457190C Promoters exhibiting endothelial cell specificity and methods of using same |
| 02/04/2009 | CN100457187C VEGF slowly releasing injection microsphere support and its preparation and use |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457183C Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 02/04/2009 | CN100457182C Behavior chemotherapy |
| 02/04/2009 | CN100457124C Therapeutic agents |
| 02/04/2009 | CN100457123C Calmophil, pharmaceutical composition for treating pulmonary surfactant system disorder and producing method thereof |
| 02/04/2009 | CN100457122C Medicine containing trivalent chromium ions for prevention and/or treatment of amyloidosis |
| 02/04/2009 | CN100457109C Stammering treating medicine and its preparing method |
| 02/04/2009 | CN100457102C Pharmaceutical compositions |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |